Recently, the effect of Drp1 inhibition using Mdivi-1 [32] on Aβ-mediated mitochondrial dysfunction and AD-associated neuropathology in cultured neurons and APP/PS1 double-transgenic AD mice has been investigated wherein the authors found pronounced improvement in both models tested [33]. Here, PSEN1 is linked to Alzheimer disease.